Citadel Advisors »

Cellectar Biosciences shares owned by Citadel Advisors

Quarter-by-quarter ownership of Cellectar Biosciences (CLRB) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Cellectar Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cellectar Biosciences held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cellectar Biosciences by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $191k 69k 2.77
2023-06-30 $60k 31k 1.95
2022-12-31 $32k 19k 1.71

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Cellectar Biosciences

AIGH Capital Management
ADAR1 Capital Management
Nantahala Capital Management
Worth Venture Partners
Rosalind Advisors
Vanguard Group
Citadel Advisors
Raymond James & Associates
Raymond James Financial Services Advisors
LLBH Private Wealth Management
Commerce Bank N A
Simplex Trading
UBS Group
BFSG
Advisor Group Holdings

View all funds holding Cellectar Biosciences